◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

UBS J.P. Morgan CNY China Gov 1-10 UCITS ETF USD acc (JC11) ETF Overview

Name: UBS J.P. Morgan CNY China Gov 1-10 UCITS ETF USD acc (JC11) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · DATA UPDATED 2026-09-02

UBS J.P. Morgan CNY China Gov 1-10 UCITS ETF USD acc (JC11) is an exchange-traded fund managed by UBS Asset Management (Europe) S.A.. It manages roughly €13 million in assets.

Interactive chart & fund stats →

JC11 Fund Statistics

Expense ratio	0.33%
Assets under management	€13 million
Fund family	UBS Asset Management (Europe) S.A.
Inception	2020-03-31

The live price chart, fund profile and news are in the interactive JC11 viewer.

Other Companies in —

HPJS · HSBC MSCI Japan Climate Paris Aligned UCITS ETF — £13 million
SMTV · VanEck Morningstar US SMID Moat UCITS ETF A Acc — £13 million
EDEV · BNP PARIBAS EASY - JPM Tilted EMU Government Bond IG 7-10Y UCITS ETF CAPITALISATION — €13 million
XNZU · Xtrackers USA Net Zero Pathway Paris Aligned UCITS ETF 1C EUR Acc — $13 million
CIB0 · VanEck Medical Robotics and Bionic Engineering UCITS ETF — €13 million
CYBG · VanEck Medical Robotics and Bionic Engineering UCITS ETF — £13 million
XFNT · Xtrackers MSCI Fintech Innovation UCITS ETF 1C USD Acc — €12 million
XFSN · Xtrackers MSCI Fintech Innovation UCITS ETF 1C USD Acc — £12 million

← JBTM All “J” companies JCAL →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.